FLEXION THERAPEUTICS INC - COM (FLXN)

CUSIP: 33938J106

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
23,485,670
Share change
+2,757,529
Total reported value
$632,110,014
Put/Call ratio
121%
Price per share
$26.91
Number of holders
100
Value change
+$78,182,568
Number of buys
53
Number of sells
41

Quarterly Holders Quick Answers

What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q1 2017

As of 31 Mar 2017, FLEXION THERAPEUTICS INC - COM (FLXN) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,485,670 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, Capital World Investors, Bank of New York Mellon Corp, BlackRock Inc., Novo A/S, KINGDON CAPITAL MANAGEMENT, L.L.C., VANGUARD GROUP INC, TPG Group Holdings (SBS) Advisors, Inc., STATE STREET CORP, and PEREGRINE CAPITAL MANAGEMENT LLC. This page lists 100 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.